The Amgen Inc. (AMGN) revenue growth is 20.9%, which is lower than the industry median of 5.6% and the 5-year historical average of 5.2%.
The Amgen Inc. (AMGN) operating income growth is (32.4%), compared to the industry median of 2.9% and the 5-year historical average of (5.4%).
The Amgen Inc. (AMGN) EPS growth is (44.3%), compared to the industry median of (12.2%) and the 5-year historical average of (4.6%).
The Amgen Inc. (AMGN) Free Cash Flow growth is (33.0%), compared to the industry median of 18.1% and the 5-year historical average of (5.9%).